Schuppli-Nollet; Marlene

Patent Applications and Registrations

Patent applications and USPTO patent grants for Schuppli-Nollet; Marlene.The latest application filed is for "novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases".

Company Profile

0.9.9

Schuppli-Nollet; Marlene - Le Bar sur Loup FR
SCHUPPLI-NOLLET; Marlene - Le Rouret FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases Grant 9,580,412 - Musicki , et al. February 28, 2	2017-02-28
Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies Grant 9,526,732 - Musicki , et al. December 27, 2	2016-12-27
Novel Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione Compounds For Use In The Treatment Of Chemokine-mediated Diseases App 20160362403 - MUSICKI; Branislav ; et al.	2016-12-15
Novel Benzenesulfonamide Compounds, Method For Synthesizing Same, And Use Thereof In Medicine As Well As In Cosmetics App 20160280650 - CLARY; Laurence ; et al.	2016-09-29
Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases Grant 9,415,039 - Musicki , et al. August 16, 2	2016-08-16
Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases Grant 9,388,149 - Musicki , et al. July 12, 2	2016-07-12
Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione Compounds For Use In The Treatment Of Chemokine-mediated Diseases App 20160166562 - MUSICKI; Branislav ; et al.	2016-06-16
Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics Grant 9,365,529 - Clary , et al. June 14, 2	2016-06-14
Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione Compounds For Use In The Treatment Of Chemokine-mediated Pathologies App 20150374708 - MUSICKI; Branislav ; et al.	2015-12-31
Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases Grant 9,120,772 - Musicki , et al. September 1, 2	2015-09-01
Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies Grant 9,090,596 - Musicki , et al. July 28, 2	2015-07-28
Novel Benzenesulfonamide Compounds, Method For Synthesizing Same, And Use Thereof In Medicine As Well As In Cosmetics App 20150158834 - CLARY; Laurence ; et al.	2015-06-11
Novel Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione Compounds For Use In The Treatment Of Chemokine-mediated Diseases App 20150087675 - Musicki; Branislav ; et al.	2015-03-26
Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics Grant 8,980,897 - Clary , et al. March 17, 2	2015-03-17
Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione Compounds For Use In The Treatment Of Chemokine-mediated Pathologies App 20140309208 - Musicki; Branislav ; et al.	2014-10-16
Novel Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione Compounds For Use In The Treatment Of Chemokine-mediated Diseases App 20140296254 - Musicki; Branislav ; et al.	2014-10-02
Novel Benzenesulfonamide Compounds, Method For Synthesizing Same, And Use Thereof In Medicine As Well As In Cosmetics App 20140107129 - CLARY; Laurence ; et al.	2014-04-17
Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics Grant 8,633,196 - Clary , et al. January 21, 2	2014-01-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.